nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—hematologic cancer	0.431	1	CbGaD
Sodium lauryl sulfate—ALB—Imatinib—hematologic cancer	0.0807	0.383	CbGbCtD
Sodium lauryl sulfate—ALB—Prednisone—hematologic cancer	0.0532	0.252	CbGbCtD
Sodium lauryl sulfate—ALB—Irinotecan—hematologic cancer	0.0504	0.239	CbGbCtD
Sodium lauryl sulfate—ALB—Methotrexate—hematologic cancer	0.0267	0.126	CbGbCtD
Sodium lauryl sulfate—Vomiting—Alitretinoin—hematologic cancer	6.75e-05	0.000193	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Triamcinolone—hematologic cancer	6.75e-05	0.000193	CcSEcCtD
Sodium lauryl sulfate—Headache—Carmustine—hematologic cancer	6.71e-05	0.000192	CcSEcCtD
Sodium lauryl sulfate—Shock—Betamethasone—hematologic cancer	6.71e-05	0.000192	CcSEcCtD
Sodium lauryl sulfate—Shock—Dexamethasone—hematologic cancer	6.71e-05	0.000192	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Triamcinolone—hematologic cancer	6.7e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—Rash—Alitretinoin—hematologic cancer	6.69e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Alitretinoin—hematologic cancer	6.69e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Ifosfamide—hematologic cancer	6.67e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Cisplatin—hematologic cancer	6.66e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Dexamethasone—hematologic cancer	6.65e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Betamethasone—hematologic cancer	6.65e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Headache—Alitretinoin—hematologic cancer	6.65e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Gemcitabine—hematologic cancer	6.64e-05	0.00019	CcSEcCtD
Sodium lauryl sulfate—Nausea—Thalidomide—hematologic cancer	6.63e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—hematologic cancer	6.62e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Rash—Ifosfamide—hematologic cancer	6.61e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Ifosfamide—hematologic cancer	6.61e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Betamethasone—hematologic cancer	6.59e-05	0.000188	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Dexamethasone—hematologic cancer	6.59e-05	0.000188	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Irinotecan—hematologic cancer	6.59e-05	0.000188	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Etoposide—hematologic cancer	6.58e-05	0.000188	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Etoposide—hematologic cancer	6.55e-05	0.000187	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Etoposide—hematologic cancer	6.55e-05	0.000187	CcSEcCtD
Sodium lauryl sulfate—Syncope—Prednisone—hematologic cancer	6.52e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—hematologic cancer	6.5e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vincristine—hematologic cancer	6.5e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Betamethasone—hematologic cancer	6.5e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Dexamethasone—hematologic cancer	6.5e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Prednisolone—hematologic cancer	6.49e-05	0.000186	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Cisplatin—hematologic cancer	6.49e-05	0.000185	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Triamcinolone—hematologic cancer	6.48e-05	0.000185	CcSEcCtD
Sodium lauryl sulfate—Rash—Vincristine—hematologic cancer	6.45e-05	0.000184	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vincristine—hematologic cancer	6.44e-05	0.000184	CcSEcCtD
Sodium lauryl sulfate—Headache—Vincristine—hematologic cancer	6.41e-05	0.000183	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Prednisone—hematologic cancer	6.39e-05	0.000183	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Betamethasone—hematologic cancer	6.37e-05	0.000182	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Dexamethasone—hematologic cancer	6.37e-05	0.000182	CcSEcCtD
Sodium lauryl sulfate—Nausea—Carmustine—hematologic cancer	6.36e-05	0.000182	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Mitoxantrone—hematologic cancer	6.33e-05	0.000181	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Irinotecan—hematologic cancer	6.33e-05	0.000181	CcSEcCtD
Sodium lauryl sulfate—Nausea—Alitretinoin—hematologic cancer	6.3e-05	0.00018	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Prednisone—hematologic cancer	6.3e-05	0.00018	CcSEcCtD
Sodium lauryl sulfate—Rash—Irinotecan—hematologic cancer	6.28e-05	0.000179	CcSEcCtD
Sodium lauryl sulfate—Rash—Mitoxantrone—hematologic cancer	6.28e-05	0.000179	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Irinotecan—hematologic cancer	6.27e-05	0.000179	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Mitoxantrone—hematologic cancer	6.27e-05	0.000179	CcSEcCtD
Sodium lauryl sulfate—Headache—Mitoxantrone—hematologic cancer	6.24e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Headache—Irinotecan—hematologic cancer	6.24e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Nausea—Ifosfamide—hematologic cancer	6.23e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Cisplatin—hematologic cancer	6.19e-05	0.000177	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Prednisone—hematologic cancer	6.17e-05	0.000176	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Gemcitabine—hematologic cancer	6.17e-05	0.000176	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Dexamethasone—hematologic cancer	6.12e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Betamethasone—hematologic cancer	6.12e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Rash—Gemcitabine—hematologic cancer	6.12e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Gemcitabine—hematologic cancer	6.11e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Etoposide—hematologic cancer	6.1e-05	0.000174	CcSEcCtD
Sodium lauryl sulfate—Headache—Gemcitabine—hematologic cancer	6.08e-05	0.000174	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vincristine—hematologic cancer	6.07e-05	0.000174	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Prednisolone—hematologic cancer	6.02e-05	0.000172	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—hematologic cancer	6.02e-05	0.000172	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Triamcinolone—hematologic cancer	5.97e-05	0.000171	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Methotrexate—hematologic cancer	5.95e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Etoposide—hematologic cancer	5.94e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Triamcinolone—hematologic cancer	5.94e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Prednisone—hematologic cancer	5.94e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Oedema—Prednisone—hematologic cancer	5.94e-05	0.00017	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Dexamethasone—hematologic cancer	5.93e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Betamethasone—hematologic cancer	5.93e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Nausea—Irinotecan—hematologic cancer	5.92e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Nausea—Mitoxantrone—hematologic cancer	5.92e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Infection—Prednisone—hematologic cancer	5.9e-05	0.000169	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Betamethasone—hematologic cancer	5.88e-05	0.000168	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Dexamethasone—hematologic cancer	5.88e-05	0.000168	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Etoposide—hematologic cancer	5.86e-05	0.000167	CcSEcCtD
Sodium lauryl sulfate—Shock—Prednisone—hematologic cancer	5.84e-05	0.000167	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—hematologic cancer	5.84e-05	0.000167	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Prednisone—hematologic cancer	5.79e-05	0.000166	CcSEcCtD
Sodium lauryl sulfate—Nausea—Gemcitabine—hematologic cancer	5.76e-05	0.000165	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Cisplatin—hematologic cancer	5.75e-05	0.000164	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Prednisone—hematologic cancer	5.74e-05	0.000164	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Methotrexate—hematologic cancer	5.73e-05	0.000164	CcSEcCtD
Sodium lauryl sulfate—Rash—Cisplatin—hematologic cancer	5.7e-05	0.000163	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Cisplatin—hematologic cancer	5.7e-05	0.000163	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Etoposide—hematologic cancer	5.67e-05	0.000162	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Prednisone—hematologic cancer	5.66e-05	0.000162	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—hematologic cancer	5.61e-05	0.00016	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.57e-05	0.000159	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Betamethasone—hematologic cancer	5.57e-05	0.000159	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—hematologic cancer	5.57e-05	0.000159	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Triamcinolone—hematologic cancer	5.54e-05	0.000158	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Etoposide—hematologic cancer	5.48e-05	0.000157	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Dexamethasone—hematologic cancer	5.42e-05	0.000155	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Betamethasone—hematologic cancer	5.42e-05	0.000155	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Prednisolone—hematologic cancer	5.4e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—hematologic cancer	5.4e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Triamcinolone—hematologic cancer	5.39e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Betamethasone—hematologic cancer	5.39e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Dexamethasone—hematologic cancer	5.39e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Betamethasone—hematologic cancer	5.39e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Dexamethasone—hematologic cancer	5.39e-05	0.000154	CcSEcCtD
Sodium lauryl sulfate—Nausea—Cisplatin—hematologic cancer	5.37e-05	0.000153	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—hematologic cancer	5.36e-05	0.000153	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Prednisone—hematologic cancer	5.33e-05	0.000152	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Triamcinolone—hematologic cancer	5.32e-05	0.000152	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Methotrexate—hematologic cancer	5.27e-05	0.000151	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Etoposide—hematologic cancer	5.27e-05	0.000151	CcSEcCtD
Sodium lauryl sulfate—Rash—Etoposide—hematologic cancer	5.22e-05	0.000149	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Etoposide—hematologic cancer	5.22e-05	0.000149	CcSEcCtD
Sodium lauryl sulfate—Headache—Etoposide—hematologic cancer	5.19e-05	0.000148	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—hematologic cancer	5.19e-05	0.000148	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Methotrexate—hematologic cancer	5.18e-05	0.000148	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Prednisone—hematologic cancer	5.16e-05	0.000148	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—hematologic cancer	5.16e-05	0.000147	CcSEcCtD
Sodium lauryl sulfate—Rash—Prednisolone—hematologic cancer	5.15e-05	0.000147	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Prednisolone—hematologic cancer	5.15e-05	0.000147	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Prednisone—hematologic cancer	5.12e-05	0.000146	CcSEcCtD
Sodium lauryl sulfate—Headache—Prednisolone—hematologic cancer	5.12e-05	0.000146	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—hematologic cancer	5.1e-05	0.000146	CcSEcCtD
Sodium lauryl sulfate—Constipation—Prednisone—hematologic cancer	5.08e-05	0.000145	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—hematologic cancer	5.03e-05	0.000144	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—hematologic cancer	5e-05	0.000143	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Triamcinolone—hematologic cancer	4.97e-05	0.000142	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Methotrexate—hematologic cancer	4.96e-05	0.000142	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—hematologic cancer	4.96e-05	0.000142	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—hematologic cancer	4.93e-05	0.000141	CcSEcCtD
Sodium lauryl sulfate—Infection—Methotrexate—hematologic cancer	4.93e-05	0.000141	CcSEcCtD
Sodium lauryl sulfate—Nausea—Etoposide—hematologic cancer	4.92e-05	0.000141	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—CRP—hematologic cancer	4.92e-05	0.0057	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Betamethasone—hematologic cancer	4.89e-05	0.00014	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Dexamethasone—hematologic cancer	4.89e-05	0.00014	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Prednisone—hematologic cancer	4.85e-05	0.000139	CcSEcCtD
Sodium lauryl sulfate—Nausea—Prednisolone—hematologic cancer	4.85e-05	0.000139	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—hematologic cancer	4.84e-05	0.000138	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—hematologic cancer	4.83e-05	0.000138	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Dexamethasone—hematologic cancer	4.82e-05	0.000138	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Betamethasone—hematologic cancer	4.82e-05	0.000138	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Methotrexate—hematologic cancer	4.8e-05	0.000137	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—SOD2—hematologic cancer	4.78e-05	0.00554	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Triamcinolone—hematologic cancer	4.78e-05	0.000137	CcSEcCtD
Sodium lauryl sulfate—Rash—Triamcinolone—hematologic cancer	4.74e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Triamcinolone—hematologic cancer	4.73e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Methotrexate—hematologic cancer	4.73e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—hematologic cancer	4.72e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Prednisone—hematologic cancer	4.72e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Headache—Triamcinolone—hematologic cancer	4.71e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Prednisone—hematologic cancer	4.69e-05	0.000134	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Prednisone—hematologic cancer	4.69e-05	0.000134	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Betamethasone—hematologic cancer	4.66e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Dexamethasone—hematologic cancer	4.66e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.65e-05	0.0054	CbGpPWpGaD
Sodium lauryl sulfate—Palpitations—Doxorubicin—hematologic cancer	4.65e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—hematologic cancer	4.64e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—hematologic cancer	4.64e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Methotrexate—hematologic cancer	4.64e-05	0.000133	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL4—hematologic cancer	4.63e-05	0.00537	CbGpPWpGaD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—hematologic cancer	4.63e-05	0.000132	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—hematologic cancer	4.61e-05	0.000132	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—hematologic cancer	4.57e-05	0.000131	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—hematologic cancer	4.56e-05	0.00013	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—CD2—hematologic cancer	4.55e-05	0.00528	CbGpPWpGaD
Sodium lauryl sulfate—Tachycardia—Epirubicin—hematologic cancer	4.53e-05	0.00013	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—ICAM1—hematologic cancer	4.52e-05	0.00524	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Dexamethasone—hematologic cancer	4.51e-05	0.000129	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Betamethasone—hematologic cancer	4.51e-05	0.000129	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—PDGFA—hematologic cancer	4.51e-05	0.00522	CbGpPWpGaD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—hematologic cancer	4.49e-05	0.000128	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—hematologic cancer	4.48e-05	0.000128	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—hematologic cancer	4.47e-05	0.000128	CcSEcCtD
Sodium lauryl sulfate—Nausea—Triamcinolone—hematologic cancer	4.46e-05	0.000128	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Methotrexate—hematologic cancer	4.46e-05	0.000127	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.45e-05	0.00516	CbGpPWpGaD
Sodium lauryl sulfate—Anorexia—Epirubicin—hematologic cancer	4.43e-05	0.000126	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Methotrexate—hematologic cancer	4.42e-05	0.000126	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Prednisone—hematologic cancer	4.37e-05	0.000125	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—hematologic cancer	4.34e-05	0.000124	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Dexamethasone—hematologic cancer	4.33e-05	0.000124	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Betamethasone—hematologic cancer	4.33e-05	0.000124	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Methotrexate—hematologic cancer	4.31e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—GNA13—hematologic cancer	4.31e-05	0.005	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Betamethasone—hematologic cancer	4.3e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—Rash—Dexamethasone—hematologic cancer	4.3e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—hematologic cancer	4.3e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—hematologic cancer	4.3e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Dexamethasone—hematologic cancer	4.29e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Betamethasone—hematologic cancer	4.29e-05	0.000123	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PDGFA—hematologic cancer	4.29e-05	0.00498	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Methotrexate—hematologic cancer	4.28e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—Headache—Betamethasone—hematologic cancer	4.27e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—Headache—Dexamethasone—hematologic cancer	4.27e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—hematologic cancer	4.27e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Prednisone—hematologic cancer	4.26e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—hematologic cancer	4.23e-05	0.000121	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—MTHFR—hematologic cancer	4.21e-05	0.00488	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Prednisone—hematologic cancer	4.2e-05	0.00012	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—hematologic cancer	4.19e-05	0.00012	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—hematologic cancer	4.17e-05	0.000119	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—hematologic cancer	4.15e-05	0.000119	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	4.14e-05	0.0048	CbGpPWpGaD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—hematologic cancer	4.14e-05	0.000118	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—JAK3—hematologic cancer	4.11e-05	0.00477	CbGpPWpGaD
Sodium lauryl sulfate—Anorexia—Doxorubicin—hematologic cancer	4.1e-05	0.000117	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—HGF—hematologic cancer	4.08e-05	0.00473	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Prednisone—hematologic cancer	4.06e-05	0.000116	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Methotrexate—hematologic cancer	4.06e-05	0.000116	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CD9—hematologic cancer	4.05e-05	0.0047	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Betamethasone—hematologic cancer	4.05e-05	0.000116	CcSEcCtD
Sodium lauryl sulfate—Nausea—Dexamethasone—hematologic cancer	4.05e-05	0.000116	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—CCL2—hematologic cancer	4.05e-05	0.00469	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—hematologic cancer	4.04e-05	0.000115	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—hematologic cancer	4.01e-05	0.000115	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—hematologic cancer	4e-05	0.000114	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CRP—hematologic cancer	4e-05	0.00464	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Epirubicin—hematologic cancer	3.97e-05	0.000113	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Methotrexate—hematologic cancer	3.94e-05	0.000113	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Prednisone—hematologic cancer	3.93e-05	0.000112	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Methotrexate—hematologic cancer	3.92e-05	0.000112	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Methotrexate—hematologic cancer	3.92e-05	0.000112	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—HGF—hematologic cancer	3.89e-05	0.00451	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CD58—hematologic cancer	3.87e-05	0.00449	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—THPO—hematologic cancer	3.87e-05	0.00449	CbGpPWpGaD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—hematologic cancer	3.86e-05	0.00011	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL3RA—hematologic cancer	3.84e-05	0.00445	CbGpPWpGaD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—hematologic cancer	3.83e-05	0.000109	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—hematologic cancer	3.8e-05	0.000109	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SOD2—hematologic cancer	3.8e-05	0.0044	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.79e-05	0.00439	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Prednisone—hematologic cancer	3.77e-05	0.000108	CcSEcCtD
Sodium lauryl sulfate—Rash—Prednisone—hematologic cancer	3.74e-05	0.000107	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Prednisone—hematologic cancer	3.74e-05	0.000107	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—hematologic cancer	3.73e-05	0.000107	CcSEcCtD
Sodium lauryl sulfate—Headache—Prednisone—hematologic cancer	3.72e-05	0.000106	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—hematologic cancer	3.71e-05	0.0043	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Doxorubicin—hematologic cancer	3.7e-05	0.000106	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—hematologic cancer	3.69e-05	0.000105	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—ICAM1—hematologic cancer	3.68e-05	0.00427	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Doxorubicin—hematologic cancer	3.67e-05	0.000105	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—hematologic cancer	3.67e-05	0.000105	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—hematologic cancer	3.67e-05	0.000105	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Methotrexate—hematologic cancer	3.66e-05	0.000104	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.6e-05	0.00418	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Methotrexate—hematologic cancer	3.56e-05	0.000102	CcSEcCtD
Sodium lauryl sulfate—Nausea—Prednisone—hematologic cancer	3.53e-05	0.000101	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.51e-05	0.0001	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—PDGFB—hematologic cancer	3.51e-05	0.00407	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Methotrexate—hematologic cancer	3.51e-05	0.0001	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—SRGN—hematologic cancer	3.45e-05	0.004	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IFNG—hematologic cancer	3.44e-05	0.00399	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—hematologic cancer	3.42e-05	9.78e-05	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—hematologic cancer	3.41e-05	9.75e-05	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—hematologic cancer	3.4e-05	9.71e-05	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—hematologic cancer	3.4e-05	9.71e-05	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Methotrexate—hematologic cancer	3.39e-05	9.7e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.35e-05	0.00388	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—hematologic cancer	3.34e-05	0.00388	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—MTHFR—hematologic cancer	3.34e-05	0.00387	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Epirubicin—hematologic cancer	3.33e-05	9.52e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—CCL2—hematologic cancer	3.29e-05	0.00382	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MPL—hematologic cancer	3.29e-05	0.00381	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Epirubicin—hematologic cancer	3.29e-05	9.39e-05	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Methotrexate—hematologic cancer	3.28e-05	9.38e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—RAC2—hematologic cancer	3.21e-05	0.00373	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CRP—hematologic cancer	3.18e-05	0.00369	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—hematologic cancer	3.18e-05	9.08e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—FN1—hematologic cancer	3.17e-05	0.00367	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—hematologic cancer	3.17e-05	9.05e-05	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Methotrexate—hematologic cancer	3.15e-05	9.02e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—S100A10—hematologic cancer	3.15e-05	0.00366	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Methotrexate—hematologic cancer	3.13e-05	8.94e-05	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Methotrexate—hematologic cancer	3.13e-05	8.93e-05	CcSEcCtD
Sodium lauryl sulfate—Headache—Methotrexate—hematologic cancer	3.11e-05	8.88e-05	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—hematologic cancer	3.08e-05	8.81e-05	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—hematologic cancer	3.07e-05	8.78e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL1B—hematologic cancer	3.07e-05	0.00356	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Doxorubicin—hematologic cancer	3.04e-05	8.69e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—GATA2—hematologic cancer	3.04e-05	0.00352	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—hematologic cancer	3.02e-05	0.0035	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Epirubicin—hematologic cancer	2.95e-05	8.44e-05	CcSEcCtD
Sodium lauryl sulfate—Nausea—Methotrexate—hematologic cancer	2.95e-05	8.42e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	2.94e-05	0.00341	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—hematologic cancer	2.94e-05	8.4e-05	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—hematologic cancer	2.93e-05	8.37e-05	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—hematologic cancer	2.93e-05	8.36e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	2.92e-05	0.00339	CbGpPWpGaD
Sodium lauryl sulfate—Headache—Epirubicin—hematologic cancer	2.91e-05	8.31e-05	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—hematologic cancer	2.84e-05	8.12e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IFNG—hematologic cancer	2.8e-05	0.00325	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.78e-05	0.00322	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	2.78e-05	0.00322	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Epirubicin—hematologic cancer	2.76e-05	7.88e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—ATP1B1—hematologic cancer	2.76e-05	0.0032	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Doxorubicin—hematologic cancer	2.73e-05	7.81e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.73e-05	0.00317	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Doxorubicin—hematologic cancer	2.71e-05	7.74e-05	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—hematologic cancer	2.71e-05	7.74e-05	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—hematologic cancer	2.69e-05	7.69e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	2.69e-05	0.00312	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.68e-05	0.0031	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.67e-05	0.00309	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	2.62e-05	0.00303	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GATA1—hematologic cancer	2.61e-05	0.00303	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	2.6e-05	0.00301	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	2.56e-05	0.00297	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Doxorubicin—hematologic cancer	2.55e-05	7.29e-05	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.54e-05	0.00294	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL1B—hematologic cancer	2.5e-05	0.00289	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL2—hematologic cancer	2.49e-05	0.00288	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ANXA2—hematologic cancer	2.39e-05	0.00277	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.39e-05	0.00277	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	2.3e-05	0.00267	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	2.26e-05	0.00263	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.26e-05	0.00262	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	2.23e-05	0.00258	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	2.23e-05	0.00258	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	2.22e-05	0.00258	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GNA13—hematologic cancer	2.22e-05	0.00258	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	2.22e-05	0.00257	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.18e-05	0.00252	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—JAK3—hematologic cancer	2.12e-05	0.00246	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGAX—hematologic cancer	2.12e-05	0.00246	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CD9—hematologic cancer	2.09e-05	0.00242	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—F3—hematologic cancer	2.09e-05	0.00242	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.07e-05	0.0024	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.07e-05	0.0024	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.07e-05	0.0024	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SELL—hematologic cancer	2.03e-05	0.00236	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	2e-05	0.00232	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	2e-05	0.00232	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	1.98e-05	0.0023	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL3RA—hematologic cancer	1.98e-05	0.0023	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.9e-05	0.00221	CbGpPWpGaD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.87e-05	0.00216	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.86e-05	0.00216	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PHYH—hematologic cancer	1.85e-05	0.00214	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GMPS—hematologic cancer	1.85e-05	0.00214	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—FTCD—hematologic cancer	1.85e-05	0.00214	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.83e-05	0.00212	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.81e-05	0.0021	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TNF—hematologic cancer	1.81e-05	0.0021	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—FGR—hematologic cancer	1.81e-05	0.0021	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—H3F3B—hematologic cancer	1.81e-05	0.0021	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.81e-05	0.0021	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.8e-05	0.00208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.79e-05	0.00208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGAL—hematologic cancer	1.74e-05	0.00202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MYB—hematologic cancer	1.74e-05	0.00202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.74e-05	0.00202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.73e-05	0.002	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.73e-05	0.002	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.73e-05	0.002	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.72e-05	0.00199	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SMPD3—hematologic cancer	1.69e-05	0.00196	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.68e-05	0.00195	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.66e-05	0.00193	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—RAC2—hematologic cancer	1.66e-05	0.00192	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.64e-05	0.0019	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.61e-05	0.00187	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TP53—hematologic cancer	1.6e-05	0.00185	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.58e-05	0.00184	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.57e-05	0.00182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.56e-05	0.00181	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.53e-05	0.00178	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SH2B3—hematologic cancer	1.5e-05	0.00174	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.5e-05	0.00173	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—B3GAT1—hematologic cancer	1.47e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ASNS—hematologic cancer	1.47e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—DCK—hematologic cancer	1.47e-05	0.00171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL6—hematologic cancer	1.46e-05	0.0017	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.45e-05	0.00168	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.44e-05	0.00167	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.44e-05	0.00167	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SPARC—hematologic cancer	1.43e-05	0.00166	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.41e-05	0.00164	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.4e-05	0.00163	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HDC—hematologic cancer	1.4e-05	0.00162	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—LCK—hematologic cancer	1.39e-05	0.00161	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.37e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.36e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—H3F3A—hematologic cancer	1.36e-05	0.00158	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GATA3—hematologic cancer	1.35e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.34e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HSPA5—hematologic cancer	1.34e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.33e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCZ—hematologic cancer	1.32e-05	0.00153	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.3e-05	0.00151	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CDA—hematologic cancer	1.28e-05	0.00148	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HDAC2—hematologic cancer	1.23e-05	0.00143	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PC—hematologic cancer	1.23e-05	0.00143	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGA4—hematologic cancer	1.22e-05	0.00141	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CD44—hematologic cancer	1.22e-05	0.00141	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC35B2—hematologic cancer	1.19e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GBA—hematologic cancer	1.19e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.19e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL3—hematologic cancer	1.19e-05	0.00138	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.18e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IFNA1—hematologic cancer	1.18e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PTPN1—hematologic cancer	1.17e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.16e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—RASGRP1—hematologic cancer	1.15e-05	0.00133	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SYK—hematologic cancer	1.14e-05	0.00133	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.12e-05	0.00129	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IFNA2—hematologic cancer	1.1e-05	0.00127	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTAP—hematologic cancer	1.09e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.08e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—GRB2—hematologic cancer	1.03e-05	0.0012	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PDGFA—hematologic cancer	1.03e-05	0.00119	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.03e-05	0.00119	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.97e-06	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ABL1—hematologic cancer	9.93e-06	0.00115	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—FHL2—hematologic cancer	9.69e-06	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AGRN—hematologic cancer	9.5e-06	0.0011	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	9.46e-06	0.0011	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HGF—hematologic cancer	9.33e-06	0.00108	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CSF2—hematologic cancer	9.23e-06	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—IDH2—hematologic cancer	9.01e-06	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HMMR—hematologic cancer	9.01e-06	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—JAK1—hematologic cancer	8.91e-06	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCG—hematologic cancer	8.91e-06	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.5e-06	0.000985	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ARNTL—hematologic cancer	8.47e-06	0.000982	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.32e-06	0.000965	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL2RA—hematologic cancer	8.32e-06	0.000964	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	8.26e-06	0.000957	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CA9—hematologic cancer	8.24e-06	0.000955	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ACP5—hematologic cancer	8.24e-06	0.000955	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOR2—hematologic cancer	8.13e-06	0.000943	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	8.04e-06	0.000932	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PDGFB—hematologic cancer	8.03e-06	0.000931	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CDK2—hematologic cancer	7.79e-06	0.000903	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—IDH1—hematologic cancer	7.75e-06	0.000898	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTO1—hematologic cancer	7.66e-06	0.000888	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TXN—hematologic cancer	7.66e-06	0.000888	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCC3—hematologic cancer	7.66e-06	0.000888	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.61e-06	0.000882	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SPHK1—hematologic cancer	7.5e-06	0.000869	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MAPK14—hematologic cancer	7.47e-06	0.000866	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	7.38e-06	0.000855	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—FN1—hematologic cancer	7.24e-06	0.000839	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UGT1A1—hematologic cancer	7.2e-06	0.000835	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC22A1—hematologic cancer	7.01e-06	0.000812	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CRABP1—hematologic cancer	7.01e-06	0.000812	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CG—hematologic cancer	6.93e-06	0.000803	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ALOX5—hematologic cancer	6.83e-06	0.000792	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PTPN11—hematologic cancer	6.81e-06	0.000789	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NUP98—hematologic cancer	6.61e-06	0.000767	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CREBBP—hematologic cancer	6.43e-06	0.000745	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA3—hematologic cancer	6.42e-06	0.000744	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADCY7—hematologic cancer	6.42e-06	0.000744	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NUP214—hematologic cancer	6.37e-06	0.000739	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.31e-06	0.000731	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.28e-06	0.000728	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCG2—hematologic cancer	6.25e-06	0.000724	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTR—hematologic cancer	6.25e-06	0.000724	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ENO2—hematologic cancer	6.12e-06	0.00071	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CD—hematologic cancer	6.09e-06	0.000706	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTT1—hematologic cancer	5.94e-06	0.000689	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.85e-06	0.000678	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SDC1—hematologic cancer	5.81e-06	0.000673	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3R1—hematologic cancer	5.75e-06	0.000667	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—JAK2—hematologic cancer	5.59e-06	0.000648	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.56e-06	0.000645	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.55e-06	0.000643	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CB—hematologic cancer	5.31e-06	0.000616	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.24e-06	0.000607	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.13e-06	0.000595	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CD44—hematologic cancer	4.94e-06	0.000572	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NQO1—hematologic cancer	4.94e-06	0.000572	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL2—hematologic cancer	4.88e-06	0.000565	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.83e-06	0.00056	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYCS—hematologic cancer	4.67e-06	0.000542	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSP90AA1—hematologic cancer	4.64e-06	0.000538	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—EP300—hematologic cancer	4.38e-06	0.000507	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SRC—hematologic cancer	4.26e-06	0.000493	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.18e-06	0.000484	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFA—hematologic cancer	4.14e-06	0.00048	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTP1—hematologic cancer	4.12e-06	0.000477	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NRAS—hematologic cancer	4.09e-06	0.000475	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.98e-06	0.000462	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—MAPK3—hematologic cancer	3.92e-06	0.000454	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCB1—hematologic cancer	3.9e-06	0.000452	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TGFB1—hematologic cancer	3.8e-06	0.000441	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTM1—hematologic cancer	3.78e-06	0.000439	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOR1—hematologic cancer	3.78e-06	0.000439	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—KRAS—hematologic cancer	3.52e-06	0.000408	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTHFR—hematologic cancer	3.34e-06	0.000388	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CA—hematologic cancer	3.24e-06	0.000375	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TP53—hematologic cancer	3.13e-06	0.000363	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—HRAS—hematologic cancer	2.99e-06	0.000347	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.95e-06	0.000342	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CG—hematologic cancer	2.81e-06	0.000326	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT1—hematologic cancer	2.64e-06	0.000307	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CREBBP—hematologic cancer	2.61e-06	0.000302	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CD—hematologic cancer	2.47e-06	0.000286	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3R1—hematologic cancer	2.33e-06	0.00027	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CB—hematologic cancer	2.15e-06	0.00025	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTEN—hematologic cancer	1.86e-06	0.000216	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—EP300—hematologic cancer	1.77e-06	0.000206	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CA—hematologic cancer	1.31e-06	0.000152	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKT1—hematologic cancer	1.07e-06	0.000124	CbGpPWpGaD
